A new survey of U.S. scientists, FDA researchers and biomedical clinicians has found that most are concerned over FDA Commissioner nominee Scott Gottlieb’s…

A bill tabled by senior Democrats would set up a $2 billion prize fund that will try to encourage the development of more effective antibiotics for serious…

The Securities and Exchange Commission (SEC) has charged 27 companies and individuals over allegations of fraudulent promotion of stocks, as it says it has…

Most of the 27 countries remaining in the EU post-Brexit have now laid out the welcome mat for the EMA and its almost 900 workers.

As it continues its sales push for the controversial Duchenne med Exondys 51 (eteplirsen), Sarepta has taken on a new chief medical officer to help it develop…

Kite Pharma completed an FDA submission for its CAR-T therapy hours before its self-imposed target passed.

Scott Gottlieb's close links to the pharma industry have threatened to undermine his chances of becoming FDA commissioner—but he thinks he has a solution.

Corbus Pharmaceuticals has posted positive top-line data from its midstage trial of Resunab in certain cystic fibrosis (CF) patients as it plots future trials…

Swiss major Novartis is still hoping to be first to market a pioneering new class of oncology medicine known as CAR-T after getting a priority review from the…

Regulatory